SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (3083)3/10/2017 4:21:46 PM
From: tuck1 Recommendation

Recommended By
Thehammer

  Read Replies (1) | Respond to of 3158
 
Well, if GILD must have an IDO inhibitor, NLNK is available for a fraction of the price. Of course, they're a bit behind INCY. Under the radar, that stock has been on a tear since I pointed to it in mom/tif (OK, it sat there for a few months, then went on a tear). And though I came close to buying NLNK a couple of times, I never did. INCY is still a big chunk in my sister's portfolio, so if the deal does go, she'll owe me some bubbly.

Cheers, Tuck